Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
PVL after TTVR | Early SAVR in asymptomatic patients | AI for mitral valve repair | Surgical valve makes US debut
Monday, April 20, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Structural Heart Disease

PVL after TTVR linked to much lower survival rate, fewer clinical benefits

TTVR has made a major impact on heart patients all over the world. Just like aortic and mitral valve replacement, however, paravalvular leak is a serious complication that can lead to much worse outcomes.

READ MORE >
Edwards Evoque transcatheter tricuspid valve replacement TTVR.
Share on Twitter Share on Facebook Share on Linkedin

PVL after TTVR linked to much lower survival rate, fewer clinical benefits

Share on Twitter Share on Facebook Share on Linkedin
Edwards Evoque transcatheter tricuspid valve replacement TTVR.
TTVR has made a major impact on heart patients all over the world. Just like aortic and mitral valve replacement, however, paravalvular leak is a serious complication that can lead to much worse outcomes.
READ MORE >

Mount Sinai announces new global center focused on heart valve disease

The Adams Valve Institute—named after David H. Adams, MD—plans on uniting specialists to provide high-quality care, promote innovation and advocate for policy reform.

READ MORE >
The leaders of the new Adams Valve Institute at Mount Sinai are Ismail El-Hamamsy, MD, PhD, director of aortic surgery and director of the Adams Valve Institute (left), and David H. Adams, MD, the Marie-Josée and Henry R. Kravis Professor and chair of the Department of Cardiovascular Surgery at the Icahn School of Medicine, and cardiac surgeon-in-chief of the Mount Sinai Health System.
Share on Twitter Share on Facebook Share on Linkedin

Mount Sinai announces new global center focused on heart valve disease

Share on Twitter Share on Facebook Share on Linkedin
The leaders of the new Adams Valve Institute at Mount Sinai are Ismail El-Hamamsy, MD, PhD, director of aortic surgery and director of the Adams Valve Institute (left), and David H. Adams, MD, the Marie-Josée and Henry R. Kravis Professor and chair of the Department of Cardiovascular Surgery at the Icahn School of Medicine, and cardiac surgeon-in-chief of the Mount Sinai Health System.
The Adams Valve Institute—named after David H. Adams, MD—plans on uniting specialists to provide high-quality care, promote innovation and advocate for policy reform.
READ MORE >

PCI before TAVR? In older CAD patients, deferral may be the best approach

Patients with coronary artery disease and severe aortic stenosis often undergo PCI before TAVR. According to new data presented at ACC.26, however, deferring PCI is associated with comparable outcomes as well as a reduced bleeding risk.

READ MORE >
Michiel Voskuil, MD, PhD, an interventional cardiologist and professor at University Medical Center Utrecht in the Netherlands, presented his team’s data on the ACC.26 stage.
Share on Twitter Share on Facebook Share on Linkedin

PCI before TAVR? In older CAD patients, deferral may be the best approach

Share on Twitter Share on Facebook Share on Linkedin
Michiel Voskuil, MD, PhD, an interventional cardiologist and professor at University Medical Center Utrecht in the Netherlands, presented his team’s data on the ACC.26 stage.
Patients with coronary artery disease and severe aortic stenosis often undergo PCI before TAVR. According to new data presented at ACC.26, however, deferring PCI is associated with comparable outcomes as well as a reduced bleeding risk.
READ MORE >

Early SAVR in asymptomatic heart patients linked to long-term benefits

New 10-year data explored the impact of performing SAVR on asymptomatic patients with severe aortic stenosis.

READ MORE >
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
Share on Twitter Share on Facebook Share on Linkedin

Early SAVR in asymptomatic heart patients linked to long-term benefits

Share on Twitter Share on Facebook Share on Linkedin
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
New 10-year data explored the impact of performing SAVR on asymptomatic patients with severe aortic stenosis.
READ MORE >

FDA clears way for IDE pivotal trial of the Topaz tricuspid valve replacement system

The TRiCares Topaz uses a unique two-stent frame valve prosthesis for better sealing and flexibility.

READ MORE >
The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) to conduct a pivotal clinical trial for TRiCares Topaz transcatheter tricuspid valve replacement (TTVR) system in the U.S. The TTVR system uses two stent frames, one for the valve and one to engage the annulus with a membrane shirt between them to enable flexing of the outer ring to better seal against regurgitation.expansing stents
Share on Twitter Share on Facebook Share on Linkedin

FDA clears way for IDE pivotal trial of the Topaz tricuspid valve replacement system

Share on Twitter Share on Facebook Share on Linkedin
The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) to conduct a pivotal clinical trial for TRiCares Topaz transcatheter tricuspid valve replacement (TTVR) system in the U.S. The TTVR system uses two stent frames, one for the valve and one to engage the annulus with a membrane shirt between them to enable flexing of the outer ring to better seal against regurgitation.expansing stents
The TRiCares Topaz uses a unique two-stent frame valve prosthesis for better sealing and flexibility.
READ MORE >

FDA clears new AI software for mitral valve repair

Philips worked closely with Edwards Lifesciences to develop the new software.

READ MORE >
Philips has secured U.S. Food and Drug Administration (FDA) clearance for EchoNavigator R5.0 with DeviceGuide, the company’s artificial intelligence (AI)-enabled software for mitral transcatheter edge-to-edge repair (M-TEER).
Share on Twitter Share on Facebook Share on Linkedin

FDA clears new AI software for mitral valve repair

Share on Twitter Share on Facebook Share on Linkedin
Philips has secured U.S. Food and Drug Administration (FDA) clearance for EchoNavigator R5.0 with DeviceGuide, the company’s artificial intelligence (AI)-enabled software for mitral transcatheter edge-to-edge repair (M-TEER).
Philips worked closely with Edwards Lifesciences to develop the new software.
READ MORE >

AI-powered EHR alerts make a world of difference for cardiologists, heart patients

AI can help care teams identify heart patients who would benefit from TAVR or another life-changing valve intervention.

READ MORE >
robot reviewing heart data
Share on Twitter Share on Facebook Share on Linkedin

AI-powered EHR alerts make a world of difference for cardiologists, heart patients

Share on Twitter Share on Facebook Share on Linkedin
robot reviewing heart data
AI can help care teams identify heart patients who would benefit from TAVR or another life-changing valve intervention.
READ MORE >

FDA-approved surgical aortic valve implanted for first time in US

The next-generation valve from Corcym features a sutureless frame as well as laser-cut leaflets and thread holes.

READ MORE >
corcym Perceval Plus LANCELOT
Share on Twitter Share on Facebook Share on Linkedin

FDA-approved surgical aortic valve implanted for first time in US

Share on Twitter Share on Facebook Share on Linkedin
corcym Perceval Plus LANCELOT
The next-generation valve from Corcym features a sutureless frame as well as laser-cut leaflets and thread holes.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup